High-dose cytosine arabinoside in the treatment of resistant acute leukemia.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007951:Leukemia, Myeloid / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D013997:Time Factors
D003561:Cytarabine